Shows / Oncology Today with Dr Neil Love

Oncology Today with Dr Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Episodes
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers, moderated by Dr…
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
Dr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes, moderated by…
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer…
Oncology Today with Dr Neil LoveInside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
Dr Nikhil Khushalani from the Moffitt Cancer Center in Tampa, Florida, and Dr Anna Pavlick from the Weill Cornell Medicine Meyer Cancer Center in New York, New…
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love. Produced…
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Dr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging optimal management approaches for…
Oncology Today with Dr Neil LoveWhat Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis…
Oncology Today with Dr Neil LoveKey Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
Dr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent updates and future directions in the management of newly diagnosed…
Oncology Today with Dr Neil LoveInside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
Dr Jamie Chaft and Dr John Heymach discuss the optimal integration of targeted therapy and immunotherapy into the care of patients with localized non-small…
Oncology Today with Dr Neil LoveManagement of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent updates on available and novel treatment…
Oncology Today with Dr Neil LoveBispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific…
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
Dr Kathleen Moore from OU Health Stephenson Cancer Center in Oklahoma City discusses treatment decision-making for real-world cases and approved and…
Oncology Today with Dr Neil LoveWhat Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and…
Oncology Today with Dr Neil LovePractical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in…
Oncology Today with Dr Neil LoveBlastic Plasmacytoid Dendritic Cell Neoplasm
Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management approaches for blastic…
Oncology Today with Dr Neil LoveInside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
Dr Hope Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Tiffany Traina from Memorial Sloan Kettering…
Oncology Today with Dr Neil LoveEmerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein…
Oncology Today with Dr Neil LoveNovel Agents and Strategies in the Treatment of Ovarian Cancer
Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer moderated by Dr Neil…
Oncology Today with Dr Neil LoveWhat Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of…
Oncology Today with Dr Neil LoveOptimizing the Management of Metastatic Pancreatic Cancer
Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in…
Oncology Today with Dr Neil LoveThe Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD…
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Melanoma
Prof Georgina Long from the University of Sydney in Sydney, New South Wales, Australia, discusses optimizing the management of melanoma moderated by Dr Neil…
Oncology Today with Dr Neil LoveStriving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
Dr Corey Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands discuss the optimal current management of relapsed NSCLC and provide perspectives on the…
Oncology Today with Dr Neil LoveThe Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte…
Oncology Today with Dr Neil LoveExploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in…
Oncology Today with Dr Neil LoveRole of BTK Inhibitors in Therapy for Mantle Cell Lymphoma
Featuring a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr Michael Wang, moderated by Dr Neil Love. CME information and select…
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
Dr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, moderated…
Oncology Today with Dr Neil LoveSpecial Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
Dr Jeremy Abramson from Massachusetts General Hospital in Boston discusses key presentations on chronic lymphocytic leukemia and lymphomas from recent…
Oncology Today with Dr Neil LoveSpecial Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Dr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual…
Oncology Today with Dr Neil LoveCurrent and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville…
Oncology Today with Dr Neil LoveIntegrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in…
Oncology Today with Dr Neil LoveSpecial Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Dr Matthew Gubens from the University of California in San Francisco, California, discusses key presentations on lung cancer from the 2023 ASCO Annual Meeting…
Oncology Today with Dr Neil LoveSpecial Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia
Dr Kerry Rogers from the Ohio State University in Columbus, Ohio, discusses the education and care of patients with chronic lymphocytic leukemia. NCPD…
Oncology Today with Dr Neil LoveClinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
Featuring perspectives from Dr Omid Hamid and Dr Evan J Lipson moderated by Dr Neil Love. Produced by Research to Practice. CME information and select…
Oncology Today with Dr Neil LoveSpecial Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Gastrointestinal Cancers Issue
Dr Philip Philip from Henry Ford Cancer - Detroit in Michigan discusses key presentations on GI cancers from the 2023 ASCO Annual Meeting moderated by Dr Neil…
Oncology Today with Dr Neil LoveSpecial Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Dr Floor Backes from The James Cancer Hospital and Solove Research Institute in Columbus, Ohio, discusses recent updates from ASCO 2023 on the management of…
Oncology Today with Dr Neil LoveReady for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank
Drs Neeraj Agarwal, Emmanuel Antonarakis, Karim Fizazi and Susan Slovin discuss the current and future role of PARP inhibitors in the management of prostate…
Oncology Today with Dr Neil LoveOptimizing the Management of Metastatic Urothelial Bladder Cancer
Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Petros Grivas from the Fred…
Oncology Today with Dr Neil LoveSpecial Edition — Current and Future Management of Breast Cancer
Dr Heather McArthur from the UT Southwestern Medical Center in Dallas, Texas discusses key presentations on breast cancer from the 2023 ASCO Annual meeting…
Oncology Today with Dr Neil LoveSpecial Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
Dr David O’Malley from The James Cancer Center in Columbus, Ohio, discusses recent advances in the management of ovarian cancer, including presentations from…
Oncology Today with Dr Neil LoveSpecial Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal Cancers
Dr Tanios Bekaii-Saab from the Mayo Clinic in Phoenix, Arizona, discusses the role of novel therapeutic management approaches for patients with colorectal and…
Oncology Today with Dr Neil LoveNovel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
Featuring perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman. CME information and select publications here
Oncology Today with Dr Neil LoveImmune Thrombocytopenia Edition with Dr Hanny Al-Samkari
Dr Hanny Al-Samkari from Harvard Medical School in Boston, Massachusetts, discusses the presentation and management of immune thrombocytopenia. CME information…
Oncology Today with Dr Neil LoveParoxysmal Nocturnal Hemoglobinuria Edition with Dr Carlos de Castro
Dr Carlos de Castro from Duke Cancer Institute in Durham, North Carolina discusses the presentation, diagnosis and management of paroxysmal nocturnal…
Oncology Today with Dr Neil LoveSpecial Edition — Management of Hepatobiliary Cancers
Dr Robin “Katie” Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California discusses recent updates from ASCO 2023 on…
Oncology Today with Dr Neil LoveSpecial Edition — Management of Urothelial Bladder Cancer
Dr Matthew Galsky discusses recent updates from ASCO 2023 on the management of urothelial bladder cancer moderated by Dr Neil Love. Produced by Research to…
Oncology Today with Dr Neil LoveSpecial Edition — Current and Future Management of Breast Cancer
Featuring a discussion on recent presentations in breast cancer from the 2023 ASCO annual meeting with Dr Kevin Kalinsky moderated by Dr Neil Love. Produced by…
Oncology Today with Dr Neil LoveSpecial Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer
Dr Elizabeth Plimack from Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses available and emerging therapies for patients with urothelial…
Oncology Today with Dr Neil LoveThe Implications of New Research Findings for the Management of Endometrial Cancer
Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell moderated by Dr Neil Love. Produced by Research to Practice. CME information and select…
Oncology Today with Dr Neil LoveMeet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma
Dr Ian W Flinn discusses the management of Hodgkin and non-Hodgkin lymphoma. CME information and select publications here
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2 - Part Series
Dr Brian Van Tine discusses new and future research in the management of soft tissue sarcoma and related connective tissue disorders. CME information and…
Oncology Today with Dr Neil LoveKey Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition
Dr Jacob Laubach from the Dana-Farber Cancer Institute discusses key presentations in multiple myeloma from the 2022 ASH Annual Meeting. CME information and…
Oncology Today with Dr Neil LoveKey Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
Dr John Allan from Weill Cornell Medicine in New York City discusses the most important chronic lymphocytic leukemia studies presented at ASH 2022. CME…
Oncology Today with Dr Neil LoveKey Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha, Nebraska, discusses the most important lymphoma studies presented at the 2022 ASH…
Oncology Today with Dr Neil LoveManagement of Desmoid Tumors with Dr Mrinal Gounder
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York City discusses the management of desmoid tumors. CME information and select…
Oncology Today with Dr Neil LoveManagement of HER2-Altered Non-Small Cell Lung Cancer
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small…
Oncology Today with Dr Neil LoveManagement of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
Dr Edward Garon from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, discusses the management of NSCLC in patients who do not have…
Oncology Today with Dr Neil LoveKey Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek
Dr Srdan Verstovsek from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses new data with myeloproliferative neoplasms presented at…
Oncology Today with Dr Neil LoveAdvances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York City discusses recent data from clinical trials evaluating targeted therapies for…
Oncology Today with Dr Neil LoveKey Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone
Dr Richard Stone from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses new data in acute myeloid leukemia and myelodysplastic syndromes…